https://www.selleckchem.com/pr....oducts/enfortumab-ve
68 (95% confidence interval [CI] 0.64-0.72), 0.74 (95% CI 0.67-0.8 for the UK-PBC score, 0.76 (95% CI 0.72-0.81) for the MRS (1989 and 1994), and 0.80 (95% CI 0.76-0.84) for the GLOBE score. The GLOBE score showed superior discriminatory performance, but differences were not statistically different. For all scores, discriminatory performance increased in those with bilirubin 0.6 × ULN and advanced fibrosis estimated with Fibrosis-4. The predicted (median) minus observed 5-year transplant-free survival was +0.4% and
Like
Comment
Share
